Skip to content

Crexendo CXDO Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Verizon Communications logo
Verizon CommunicationsVZ
8x8, Inc. logo
8x8, Inc.EGHT
Five9 logo
Five9FIVN
Consensus Cloud Solutions, Inc. logo
Consensus Cloud Solutions, Inc.CCSI
Lumen Technologies logo
Lumen TechnologiesLUMN
Conduent Incorporated logo
Conduent IncorporatedCNDT

Other financials

Income statement

See full
Revenue$20.7M+29.0%
Gross profit$7.7M+1.8%
Operating income$440.0K-61.7%
Net income$578.0K-50.6%
EPS (diluted)$0.02-50.0%

Balance sheet

See full
Cash & equivalents$7.2M-65.8%
Total debt$995.0K-30.8%
Total equity$72.7M+31.7%
Total assets$91.3M+35.3%

Cash flow

See full
Operating cash flow$2.0M+64.5%
CapEx$18.0K
Free cash flow$2.3M+9.2%

Valuation

See full
Market cap$242.14M+42.8%
Enterprise value$235.89M+59.6%
P/E54.1×-1.4×
P/S3.3×+0.7×

Profitability

See full
Gross margin69.8%
Operating margin5.5%+1.5pp
Net margin6.1%+2.3pp
FCF margin13.6%+3.3pp

Returns & leverage

See full
Return on equity7%+2.3pp
Debt / equity0.0×
Current ratio1.4×-1.3×

Where this comes from

Reported directly by Crexendo in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Crexendo’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crexendo's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crexendo's common stock, shares authorized (in shares)?
Crexendo (CXDO) reported common stock, shares authorized (in shares) of $50M in Q1 2026.
How has Crexendo's common stock, shares authorized (in shares) changed year-over-year?
Crexendo's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $50M to $50M.
What is the long-term trend for Crexendo's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Crexendo's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $50M to $50M.